Your browser doesn't support javascript.
loading
Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys.
Bai, W; Liu, Z H; Jiang, Y Y; Zhang, Q E; Rao, W W; Cheung, T; Hall, B J; Xiang, Y T.
  • Bai W; Unit of Psychiatry, Department of Public Health and Medicinal Administration, & Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.
  • Liu ZH; Centre for Cognitive and Brain Sciences, University of Macau, Macao SAR, China.
  • Jiang YY; Institute of Advanced Studies in Humanities and Social Sciences, University of Macau, Macao SAR, China.
  • Zhang QE; Unit of Psychiatry, Department of Public Health and Medicinal Administration, & Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.
  • Rao WW; Centre for Cognitive and Brain Sciences, University of Macau, Macao SAR, China.
  • Cheung T; Institute of Advanced Studies in Humanities and Social Sciences, University of Macau, Macao SAR, China.
  • Hall BJ; Unit of Psychiatry, Department of Public Health and Medicinal Administration, & Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao SAR, China.
  • Xiang YT; Centre for Cognitive and Brain Sciences, University of Macau, Macao SAR, China.
Transl Psychiatry ; 11(1): 552, 2021 10 29.
Article en En | MEDLINE | ID: mdl-34716297
Schizophrenia is a severe psychiatric disorder with high premature mortality rates. This is a meta-analysis and systematic review of the prevalence of suicidal ideation (SI) and suicide plan (SP) among people with schizophrenia. PubMed, Web of Science, Embase, and PsycINFO were systematically searched from their respective inception to October 10, 2020. Data on prevalence of SI and/or SP were synthesized using the random effects model. Twenty-six studies covering 5079 people with schizophrenia were included for meta-analysis. The lifetime and point prevalence of SI were 34.5% (95% CI: 28.2-40.9%), and 29.9% (95% CI: 24.2-35.6%), respectively. The lifetime prevalence of SP was 44.3% and the point prevalence of SP ranged between 6.4 and 13%. Subgroup and meta-regression analyses revealed that source of patients, survey countries, and sample size were significantly associated with the point prevalence of SI, while male proportion and quality assessment scores were significantly associated with the lifetime and point prevalence of SI. Survey time and mean age were significantly associated with lifetime prevalence of SI. Both SI and SP are common in people living with schizophrenia, especially in males and inpatients. Routine screening and effective interventions for SI and SP should be implemented in this population.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Ideación Suicida Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esquizofrenia / Ideación Suicida Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Male Idioma: En Año: 2021 Tipo del documento: Article